- Home
- SXTP vs SOBR Comparison
SXTP vs SOBR Comparison
Compare SXTP & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- SOBR
- Stock Information
- Founded
- SXTP 2010
- SOBR 2004
- Country
- SXTP United States
- SOBR United States
- Employees
- SXTP N/A
- SOBR N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- SOBR Newspapers/Magazines
- Sector
- SXTP Health Care
- SOBR Consumer Discretionary
- Exchange
- SXTP Nasdaq
- SOBR Nasdaq
- Market Cap
- SXTP 5.7M
- SOBR 5.2M
- IPO Year
- SXTP 2023
- SOBR N/A
- Fundamental
- Price
- SXTP N/A
- SOBR N/A
- Analyst Decision
- SXTP Buy
- SOBR
- Analyst Count
- SXTP 2
- SOBR 0
- Target Price
- SXTP $3.00
- SOBR N/A
- AVG Volume (30 Days)
- SXTP 61.0K
- SOBR 14.9K
- Earning Date
- SXTP 11-13-2025
- SOBR 11-13-2025
- Dividend Yield
- SXTP N/A
- SOBR N/A
- EPS Growth
- SXTP N/A
- SOBR N/A
- EPS
- SXTP N/A
- SOBR N/A
- Revenue
- SXTP $984,494.00
- SOBR $301,400.00
- Revenue This Year
- SXTP $81.41
- SOBR N/A
- Revenue Next Year
- SXTP $95.63
- SOBR N/A
- P/E Ratio
- SXTP N/A
- SOBR N/A
- Revenue Growth
- SXTP 128.70
- SOBR 73.21
- 52 Week Low
- SXTP $1.22
- SOBR $2.41
- 52 Week High
- SXTP $12.45
- SOBR $193.50
- Technical
- Relative Strength Index (RSI)
- SXTP 54.01
- SOBR 43.87
- Support Level
- SXTP $1.38
- SOBR $3.18
- Resistance Level
- SXTP $1.51
- SOBR $3.35
- Average True Range (ATR)
- SXTP 0.07
- SOBR 0.12
- MACD
- SXTP 0.01
- SOBR -0.00
- Stochastic Oscillator
- SXTP 57.95
- SOBR 20.51
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About SOBR SOBR Safe Inc.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.